Related Experiment Video

Updated: Mar 25, 2026

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
10:21

Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test

Published on: September 22, 2023

1.1K

The relationship between left ventricular mass index and body composition in new-diagnosed hypertensive patients

Sebnem Karakan1, Bekir Inan2

  • 1Department of Nephrology, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.

Clinical Hypertension
|February 20, 2016
PubMed

Insights

Body fat percentage is linked to higher Left Ventricular Mass Index in new hypertension patients. Reducing body fat may lower Left Ventricular Hypertrophy risk, especially in obese individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Body Composition Analysis

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Hypertension and obesity are significant risk factors for CVD.
  • Left Ventricular Mass Index (LVMI) is a key indicator of cardiac health.

Purpose of the Study:

  • To investigate the association between body composition and LVMI in newly diagnosed hypertensive patients.
  • To determine if body fat percentage is a predictor of LVMI in this population.

Main Methods:

  • 120 newly diagnosed hypertensive patients were enrolled.
  • Body fat percentage (BFP) measured using bioelectrical impedance analysis (BIA).
  • Echocardiography used to assess LVMI.

Main Results:

  • Females had higher body fat percentage, BMI, and LVMI than males.
  • Patients with higher BFP (Group 3) showed increased BMI, inflammatory markers, and triglycerides.
  • Higher BFP was independently associated with increased LVMI, along with age, weight, and gender.

Conclusions:

  • Body fat percentage is significantly associated with higher LVMI in hypertensive patients.
  • Assessing BFP can help identify individuals at higher risk for Left Ventricular Hypertrophy (LVH).
  • Interventions targeting body fat reduction may be crucial for managing LVH in hypertensive and obese populations.
Abstract

Keywords:
Body compositionHypertensionLeft ventriculare mass index

More Related Videos

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

4.8K
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

942

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
711
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
932